An integrated disease/pharmacokinetic/pharmacodynamic model suggests improved interleukin-21 regimens validated prospectively for mouse solid cancers
Elishmereni, Moran, Kheifetz, Yuri, Søndergaard, Henrik, Overgaard, Rune Viig, Agur, Zvia
Published in PLoS computational biology (01.09.2011)
Published in PLoS computational biology (01.09.2011)
Get full text
Journal Article
A Population Pharmacokinetic Model for Concizumab Based on Phase 1 and Phase 2 Trial Data
Høyer Rose, Trine, Hollensen, Christian, Agersø, Henrik, Viig Overgaard, Rune
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Pharmacokinetics and Pharmacodynamics of Once-Weekly Somapacitan in Children and Adults: Supporting Dosing Rationales with a Model-Based Analysis of Three Phase I Trials
Juul, Rasmus Vestergaard, Rasmussen, Michael Højby, Agersø, Henrik, Overgaard, Rune Viig
Published in Clinical pharmacokinetics (01.01.2019)
Published in Clinical pharmacokinetics (01.01.2019)
Get full text
Journal Article
Impact of dose‐escalation schemes and drug discontinuation on weight loss outcomes with liraglutide 3.0 mg: A model‐based approach
Papathanasiou, Theodoros, Strathe, Anders, Agersø, Henrik, Lund, Trine Meldgaard, Overgaard, Rune Viig
Published in Diabetes, obesity & metabolism (01.06.2020)
Published in Diabetes, obesity & metabolism (01.06.2020)
Get full text
Journal Article
A model‐based approach to predict individual weight loss with semaglutide in people with overweight or obesity
Strathe, Anders, Horn, Deborah B., Larsen, Malte Selch, Rubino, Domenica, Sørrig, Rasmus, Tran, Marie Thi Dao, Wharton, Sean, Overgaard, Rune Viig
Published in Diabetes, obesity & metabolism (01.11.2023)
Published in Diabetes, obesity & metabolism (01.11.2023)
Get full text
Journal Article
Impact of dose‐escalation schemes and drug discontinuation on weight loss outcomes with liraglutide 3.0mg: A model‐based approach
Papathanasiou, Theodoros, Strathe, Anders, Agersø, Henrik, Lund, Trine Meldgaard, Overgaard, Rune Viig
Published in Diabetes, obesity & metabolism (01.06.2020)
Published in Diabetes, obesity & metabolism (01.06.2020)
Get full text
Journal Article
Pharmacokinetics of an anti-TFPI monoclonal antibody (concizumab) blocking the TFPI interaction with the active site of FXa in Cynomolgus monkeys after iv and sc administration
Agersø, Henrik, Overgaard, Rune Viig, Petersen, Mads Bjelke, Hansen, Lene, Hermit, Mette Brunsgaard, Sørensen, Mette Høgh, Petersen, Lars Christian, Hilden, Ida
Published in European journal of pharmaceutical sciences (02.06.2014)
Published in European journal of pharmaceutical sciences (02.06.2014)
Get full text
Journal Article
Clinical Pharmacokinetics of the Anti-Interleukin-20 Monoclonal Antibody NNC0109-0012 in Healthy Volunteers and Patients with Psoriasis or Rheumatoid Arthritis
Lundblad, Mia Sandberg, Overgaard, Rune Viig, Göthberg, Marie, Fjording, Marianne Scheel, Watson, Estelle
Published in Advances in therapy (01.03.2015)
Published in Advances in therapy (01.03.2015)
Get full text
Journal Article
Population stochastic modelling (PSM)—An R package for mixed-effects models based on stochastic differential equations
Klim, Søren, Mortensen, Stig Bousgaard, Kristensen, Niels Rode, Overgaard, Rune Viig, Madsen, Henrik
Published in Computer methods and programs in biomedicine (01.06.2009)
Published in Computer methods and programs in biomedicine (01.06.2009)
Get full text
Journal Article
An Integrated Disease/Pharmacokinetic/Pharmacodynamic Model Suggests Improved Interleukin-21 Regimens Validated Prospectively for Mouse Solid Cancers: e1002206
Elishmereni, Moran, Kheifetz, Yuri, Søndergaard, Henrik, Overgaard, Rune Viig, Agur, Zvia
Published in PLoS computational biology (01.09.2011)
Published in PLoS computational biology (01.09.2011)
Get full text
Journal Article
Anti-KIR antibodies, formulations, and uses thereof
Alifrangis, Lene Hjorth, Sten, Rozana, Svendsen, Ivan, Overgaard, Rune Viig, Wagtmann, Peter Andreas Nicolai Reumert
Year of Publication 27.10.2020
Get full text
Year of Publication 27.10.2020
Patent
ANTI-KIR ANTIBODIES, FORMULATIONS, AND USES THEREOF
OVERGAARD, Rune Viig, STEN, Rozana, SVENDSEN, Ivan, ALIFRANGIS, Lene Hjorth, WAGTMANN, Peter Andreas Nicolai Reumert
Year of Publication 26.07.2018
Get full text
Year of Publication 26.07.2018
Patent
Anti-KIR antibodies, formulations, and uses thereof
Sten Rozana, Overgaard Rune Viig, Wagtmann Peter Andreas Nicolai Reumert, Svendsen Ivan, Alifrangis Lene Hjorth
Year of Publication 30.01.2018
Get full text
Year of Publication 30.01.2018
Patent